高级检索
当前位置: 首页 > 详情页

Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18 KDa.

文献详情

资源类型:
Pubmed体系:
机构: [1]Shunde Hospital of Guangzhou University of TCM, Foshan, Guangdong, 528300, China [2]School of Traditional Chinese Medicine, Southern Medical University Guangzhou, Guangdong, 510515, China [3]Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, China [4]The Fifth Affiliated Hospital of Southern Medical University, China Guangzhou, Guangdong, 510900, China
出处:
ISSN:

关键词: Paeoniflorin TSPO Glioma Neurosteroids PK11195

摘要:
As a natural compound isolated from Paeoniae radix, Paeoniflorin (PF) has been shown the antitumor effects in various types of human cancers including glioma, which is one of the serious tumors in central nervous system. Translocator protein 18 KDa (TSPO) has been shown to be relevant to the glioma aetiology. However, the regulation of PF in TSPO and neurosteriods biosynthesis on glioma is still unclear. In the present study, the glioma cell (U87 and U251) were cultured and used to quantify the bindings of PF on TSPO. Results indicated that there was not significant different between IC50 of PF and TSPO ligand PK11195. Moreover, PF exerted the anti-proliferative effects in glioma cell with a dose dependent inhibition from 12.5 to 100 μM in vitro. Consistent with the effects of PK11195, lowered levels on progesterone, allopregnanolone, as well as TSPO mRNA were induced by PF (25 and 50 μM). Furthermore, a xenograft mouse model with U87 cell-derived was significant inhibited by PF treatment, as well as the PK11195 administration. These results demonstrate that PF exerts its antitumor effects associated with the TSPO and neurosteroids biosynthesis in glioma cells could be a promising therapeutic agent for glioma therapy. Copyright © 2020 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
第一作者:
第一作者机构: [1]Shunde Hospital of Guangzhou University of TCM, Foshan, Guangdong, 528300, China [2]School of Traditional Chinese Medicine, Southern Medical University Guangzhou, Guangdong, 510515, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号